New Edge Advisors, LLC Amneal Pharmaceuticals, Inc. Transaction History
New Edge Advisors, LLC
- $16 Billion
- Q4 2024
A detailed history of New Edge Advisors, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 43 shares of AMRX stock, worth $372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43Holding current value
$372% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
205Shares Held
123MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$129 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$107 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$97.8 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$93 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$77.9 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.31B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...